After Falling 41% In 1-Year, Small Cap Chemical Stock Can Surge 59%, Nuvama Says Buy

Brokerage firm Nuvama has assigned buy rating to small cap chemical sector stock, Rossari Biotech Ltd with a target price of Rs 1170 apiece. The current market price of the stock is Rs 735 with an intraday fall of over 2%. The company has a market capitalisation of Rs 4056 crore. Check key details below:

1. Rossari Biotech Ltd Share Performance

The last trading price of the stock is Rs 735 apiece. Its 52-week high is Rs 1375 and 52-week low is Rs 675 apiece, respectively. The stock witnessed a decline of 2.35% in trade on December 29.

2. Rossari Biotech Return

The stock has given 4% return in last 1-week. The stock has declined 24% in last 3-months and 41% in last 1-year. Shares of the company witnessed a decline of 7% in last 1-month.

The company for the quarter ended September 30, 2022 declared a consolidated total income of Rs 426 crore, down 2% from last quarter total income of Rs 435 crore.

3. Rossari Biotech About

The small cap company provides customized solutions to industrial and production requirements of our customers through our diversified product portfolio. Building upon our expertise from textiles, it has successfully diversified into the animal health and nutrition, home, personal care and performance chemicals markets.

Disclaimer

The stock has been picked from the brokerage report of Nuvama. Greynium Information Technologies, the Author, and the respective Brokerage House are not liable for any losses caused as a result of decisions based on the article. Goodreturns.in advises users to check with certified experts before taking any investment decision.